Stay informed with expert insights, trends, and best practices in life sciences compliance.
Three years after the initiation of the EFPIA code, member companies published their transfers of value for the first time in 2016 in order to disclose their transactions with HCPs and HCOs for 2015. Whilst transparency initiatives in themselves aren’t new (countries like the USA, Netherlands, Portugal, UK and France already had them in place), […]
The EFPIA Transparency Directive deems it necessary for all member associations within the EU to publish spend data by Pharma manufacturers on HCP/HCO. For this purpose, under the data privacy laws of the EU, it is necessary for pharmaceutical manufacturers to receive consent from HCPs prior to reporting any transfer of value details in the […]
The 4th Annual Pharma Compliance Europe Congress is being held at the Royal Garden Hotel, London, UK, on October 5th & 6th, 2016. The conference aims to bring together senior representatives from the legal, compliance, and transparency industries to discuss operational best practices and will feature an impressive list of speakers and attendees from Pfizer, […]
In the past couple of years, law enforcement agencies have recovered billions of dollars through judgments and settlements related to healthcare fraud investigations. In the fiscal year 2015, the DoJ recovered more than $3.5 billion in judgments and settlements from cases that involved fraud and false claims against the government. As time goes by, government […]
Prosecutors have indicted six executives from the South Korean unit of Novartis for paying rebates to doctors so they may prescribe the company’s drugs to patients. Twenty-eight other individuals, including fifteen doctors and six medical publishers, were also part of the prosecutorial sweep. The six executives who were prosecuted include Novartis Korea chief Moon Hak-sun. […]
CBI held the 10th Annual Forum on Transparency and Aggregate Spend at the Ritz-Carlton in Washington, D.C. from 15th – 17th August, 2016. The forum provided an excellent opportunity for pharmaceutical, biotech, and medical device executives to connect and share information about best practices pertaining to Federal, State, and worldwide HCP reporting. The conference delivered […]